Your browser doesn't support javascript.
loading
Outcome without any adjuvant systemic treatment in stage I ER+/HER2- breast cancer patients included in the MINDACT trial.
Lopes Cardozo, J M N; Byng, D; Drukker, C A; Schmidt, M K; Binuya, M A; van 't Veer, L J; Cardoso, F; Piccart, M; Smorenburg, C H; Poncet, C; Rutgers, E J T.
Afiliación
  • Lopes Cardozo JMN; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
  • Byng D; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Drukker CA; Department of Surgery, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Schmidt MK; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Binuya MA; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.
  • van 't Veer LJ; Department of Laboratory Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA.
  • Cardoso F; Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal.
  • Piccart M; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Smorenburg CH; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Poncet C; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
  • Rutgers EJT; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: e.rutgers@nki.nl.
Ann Oncol ; 33(3): 310-320, 2022 03.
Article en En | MEDLINE | ID: mdl-34861376
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama Límite: Female / Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Bélgica
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama Límite: Female / Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Bélgica